Literature DB >> 14500768

Group II metabotropic glutamate receptor modulation of excitatory transmission in rat subthalamic nucleus.

Ke-Zhong Shen1, Steven W Johnson.   

Abstract

Patch pipettes were used to record currents in whole-cell configuration to study the effects of group II metabotropic glutamate receptor (mGluR) stimulation on synaptic transmission in slices of rat subthalamic nucleus. Evoked glutamatergic excitatory postsynaptic currents (EPSCs) were reversibly reduced by the selective group II mGluR agonist (2'S,2'R,3'R)-2-(2',3'-dicarboxycyclopropyl)glycine (DCG IV) in a concentration-dependent manner, with an IC50 of 0.19 +/- 0.05 microM. DCG IV (1 microM) had no effect on inhibitory postsynaptic currents mediated by GABA. DCG IV-induced inhibition of EPSCs was reversed by the selective group II mGluR antagonist LY 341495 (100 nM) and mimicked by another selective group II agonist (2S,1'S,2'S)-2-(carboxycyclopropyl)glycine (L-CCG-I). Inhibition of EPSC amplitude by DCG IV and L-CCG-I was associated with an increase in the paired-pulse ratio of EPSCs. The protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (2 microM) reduced the inhibitory effect of DCG IV on EPSCs. However, the response to DCG IV was not affected by the protein kinase A (PKA) activator forskolin (20 microM), by the adenylyl cyclase inhibitor MDL 12230A (20 microM), or by the phosphodiesterase inhibitor Ro 20-1724 (50 microM). DCG IV-induced inhibition of EPSCs was reduced by the non-selective protein kinase inhibitors H-7 (100 microM), H-8 (50 microM) and HA-1004 (100 microM). These results suggest that group II mGluR stimulation acts presynaptically to inhibit glutamate release by a PKC-dependent mechanism in the subthalamic nucleus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500768      PMCID: PMC2343573          DOI: 10.1113/jphysiol.2003.052209

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  47 in total

1.  Activation of group II metabotropic glutamate receptors inhibits synaptic excitation of the substantia Nigra pars reticulata.

Authors:  S R Bradley; M J Marino; M Wittmann; S T Rouse; H Awad; A I Levey; P J Conn
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

2.  Metabotropic glutamate receptors mGluR1alpha and mGluR2/3 display dynamic expression patterns in developing rat striatum.

Authors:  E S Jokel; E R Garduno; M A Ariano; M S Levine
Journal:  Dev Neurosci       Date:  2001       Impact factor: 2.984

3.  Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus.

Authors:  H Awad; G W Hubert; Y Smith; A I Levey; P J Conn
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

4.  Activation of groups I or III metabotropic glutamate receptors inhibits excitatory transmission in the rat subthalamic nucleus.

Authors:  H Awad-Granko; P J Conn
Journal:  Neuropharmacology       Date:  2001-07       Impact factor: 5.250

5.  Intrasubthalamic nucleus metabotropic glutamate receptor activation: a behavioral, Fos immunohistochemical and [14C]2-deoxyglucose autoradiographic study.

Authors:  J A Kearney; R L Albin
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

6.  cAMP-dependent protein kinase inhibits mGluR2 coupling to G-proteins by direct receptor phosphorylation.

Authors:  H Schaffhauser; Z Cai; F Hubalek; T A Macek; J Pohl; T J Murphy; P J Conn
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

Review 7.  The role of striatal metabotropic glutamate receptors in Parkinson's disease.

Authors:  K Ossowska; J Konieczny; J Wardas; K Gołembiowska; S Wolfarth; A Pilc
Journal:  Amino Acids       Date:  2002       Impact factor: 3.520

8.  Immunohistochemical localization of metabotropic glutamate receptors mGluR1a and mGluR2/3 in the rat basal ganglia.

Authors:  C M Testa; I K Friberg; S W Weiss; D G Standaert
Journal:  J Comp Neurol       Date:  1998-01-05       Impact factor: 3.215

Review 9.  Distribution and roles of metabotropic glutamate receptors in the basal ganglia motor circuit: implications for treatment of Parkinson's disease and related disorders.

Authors:  S T Rouse; M J Marino; S R Bradley; H Awad; M Wittmann; P J Conn
Journal:  Pharmacol Ther       Date:  2000-12       Impact factor: 12.310

10.  Chronic but not acute treatment with a metabotropic glutamate 5 receptor antagonist reverses the akinetic deficits in a rat model of parkinsonism.

Authors:  Nathalie Breysse; Christelle Baunez; Will Spooren; Fabrizio Gasparini; Marianne Amalric
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

View more
  5 in total

Review 1.  Metabotropic Glutamate Receptors 2 and 3 as Targets for Treating Nicotine Addiction.

Authors:  Alan J Cross; Robert Anthenelli; Xia Li
Journal:  Biol Psychiatry       Date:  2017-11-21       Impact factor: 13.382

2.  Differential modulation of ethanol-induced sedation and hypnosis by metabotropic glutamate receptor antagonists in C57BL/6J mice.

Authors:  Amanda C Sharko; Clyde W Hodge
Journal:  Alcohol Clin Exp Res       Date:  2007-12-07       Impact factor: 3.455

Review 3.  Metabotropic glutamate receptors: targets for neuroprotective therapies in Parkinson disease.

Authors:  Gunasingh J Masilamoni; Yoland Smith
Journal:  Curr Opin Pharmacol       Date:  2018-03-30       Impact factor: 5.547

4.  Signaling mechanisms mediating muscarinic enhancement of GABAergic synaptic transmission in the spinal cord.

Authors:  H-M Zhang; S-R Chen; Y-Q Cai; T E Richardson; L C Driver; G Lopez-Berestein; H-L Pan
Journal:  Neuroscience       Date:  2008-12-07       Impact factor: 3.590

5.  Nicotine exposure during adolescence leads to short- and long-term changes in spike timing-dependent plasticity in rat prefrontal cortex.

Authors:  Natalia A Goriounova; Huibert D Mansvelder
Journal:  J Neurosci       Date:  2012-08-01       Impact factor: 6.167

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.